Brevan Howard Capital Management »

Recursion Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $210k 21k 9.97

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option (XLF)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)
Ametek (AME)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Msci Eafe Index Fund Msci Eafe Etf Call Option (EFA)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Ishares Russell 2000 Etf Russell 2000 Etf Call Option (IWM)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)
Spdr S&p Biotech Etf S&p Biotech Call Option (XBI)
Energy Select Sector Spdr Energy Call Option (XLE)
Spdr Metals & Mining Etf S&p Metals Mng Call Option (XME)
Streettracks Gold Trust Gold Shs Call Option (GLD)
SEMICONDUCTOR HOLDRs TRUST Semiconductr Etf (SMH)

View all positions for Brevan Howard Capital Management

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
BlackRock
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
FMR
MIC Capital Management UK
Nvidia Corp
Geode Capital Management
Exor Investments
Dimensional Fund Advisors
Morgan Stanley

View all funds holding Recursion Pharmaceuticals